Conjunctivitis Market : Key Trends and Forecast Research Report 2017 to 2023

Conjunctivitis Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Conjunctivitis Market by disease type (bacterial conjunctivitis, viral conjunctivitis, allergic conjunctivitis) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Conjunctivitis Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Conjunctivitis Market are Akorn, Alcon, Allergan, Inc., Bausch & Lomb, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Nicox, NovaBay and Ocular Therapeutix. According to the report the Global Conjunctivitis Market is projected to grow at a CAGR of 2.1% in terms of value over the period of 2017-2023.

Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or ultraviolet light. Conjunctivitis is an extremely common eye problem because the conjunctiva is continually exposed to microorganisms and environmental agents that can cause infections or allergic reactions. It can also affect one or both eyes and, if caused by infection, can be very easily transmitted to others during close physical contact, particularly among children in a daycare center. Thus, people diagnosed with conjunctivitis are recommended not to travel public places for that period of time.

Increasing Awareness among Patient Population about Pink Eye Disease, Entry of New Drugs and Unmet Need for Viral Conjunctivitis Are Considered to Be the Key Factors Driving the Growth of This Market

Unfavorable government regulations, expiring drug patents of major blockbusters and the growing demand for antibacterial drugs has impacted the demand for branded drugs are the key restraining factors for the growth of this market. Since, there are no approved drugs for the treatment of viral conjunctivitis, many companies are developing drugs which are expected to aid in the treatment of viral conjunctivitis and their effect will turn into a prominent opportunity to promote growth of this market over the forecast period. Moreover, loss of patent exclusivities and increasing demand for generic antibacterial drugs over branded drugs are the major challenges faced by this market.

Segment Covered in this Premium Report

The report on global conjunctivitis market covers segments such as, disease type. On the basis of disease type the global conjunctivitis market is categorized into bacterial conjunctivitis, viral conjunctivitis and allergic conjunctivitis.

North America to witness the highest growth during the forecast period

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China.  The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023. 

Major Key Players Mentioned in this Premium Report

The report provides profiles of the companies in the global conjunctivitis market such as, Akorn, Alcon, Allergan, Inc., Bausch & Lomb, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Nicox, NovaBay and Ocular Therapeutix.

Table of Contents:-

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

3. Global Conjunctivitis Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.5. Competitive Landscape in the Global Conjunctivitis Market

4. Global Conjunctivitis Market by Disease Type

4.1. Bacterial Conjunctivitis

4.2. Viral Conjunctivitis

4.3. Allergic Conjunctivitis

5. Global Conjunctivitis Market by Region 2017-2023

5.1. North America

5.1.1. North America Conjunctivitis Market by Disease Type

5.1.2. North America Conjunctivitis Market by Country

5.2. Europe

5.2.1. Europe Conjunctivitis Market by Disease Type

5.2.2. Europe Conjunctivitis Market by Country

5.3. Asia-Pacific

5.3.1. Asia-Pacific Conjunctivitis Market by Disease Type

5.3.2. Asia-Pacific Conjunctivitis Market by Country

5.4. RoW

5.4.1. RoW Conjunctivitis Market by Disease Type

5.4.2. RoW Conjunctivitis Market by Sub-region

6. Company Covered

6.1. Akorn

6.2. Alcon

6.3. Allergan, Inc.

6.4. Bausch & Lomb

6.5. Eleven Biotherapeutics

6.6. Griffin Discoveries

6.7. InSiteVision

6.8. Nicox

6.9. NovaBay

6.10. Ocular Therapeutix

Click the Below Full Report Link

Reset Password